The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...

You may register to present a scientific poster (all submissions are accepted), an oral presentation (only four students are selected to present; see below), or both. Shortly after you register, you ...

A unique conference format that prioritises discussion At ... in tuning and maintaining membrane asymmetry. Submit an oral/paper abstract if you wish to be considered for an oral presentation and ...

The acceptance of our results for an oral presentation also represents an important company milestone, as it reflects the scientific interest we have generated, as recognized by the largest global ...

We look forward to sharing an oral presentation on a lisaftoclax combination regimen in patients with treatment-naïve or prior venetoclax-exposed myeloid malignancies and a readout on ...

Candel Therapeutics announced an oral presentation of CAN-2409 data at the ASCO Annual Meeting, focusing on prostate cancer treatment. Candel Therapeutics, Inc. announced the acceptance of an ...

Marseille, France, April 23, 2025 10:00 a.m. ET / 4:00 p.m. CET– ImCheck Therapeutics announced today an oral presentation at the upcoming American Society of Clinical Oncology (ASCO ...

Marseille, France, April 23, 2025 10:00 a.m. ET / 4:00 p.m. CET- ImCheck Therapeutics announced today an oral presentation at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting ...

will be highlighted in an oral presentation. In addition, a trial-in-progress poster on SUPRAME, the ongoing Phase 3 clinical trial evaluating IMA203 in patients with unresectable or metastatic ...

During oral arguments Tuesday ... on the subjects are “not just exposure to the idea” but rather a “presentation of the idea as fact.” “It’s saying ‘this is the right view of ...